FDA approves Novo Nordisk’s Victoza for heart disease treatment in type 2 diabetes patients

In a significant advancement for diabetes care, Danish pharmaceutical giant Novo Nordisk has received approval from the U.S. Food and Drug Administration (FDA) to use ... Read More